top of page

First-in-Class Precision Therapies

for CMT1A & Intractable Neurological Diseases

Powered by ​PRECISION™ Neurotechnology

Healthy Nerve & Myelin Regeneration
Our Mission

CELLTIUM pioneers precision neurotechnology to create first-in-class, disease-modifying therapies for CMT1A and intractable neurological disorders.

Precision Neurotechnology & Genetic Insights
Our Technology

CELLTIUM's proprietary PRECISION™ HCS platform is built on disease-relevant models of the nervous system, integrating machine learning algorithms and fine-tuned automation.

CELLTIUM Global Bio-Pharma Team
Join Us!

CELLTIUM is seeking exceptional talent. Unleash your vision and shape the future of breakthrough medicines with us.

CELLTIUM is collaborating with leading investors and strategic partners to further biotech innovations for healthier humanity.

DAEKYO Daekyo Investment.png
SL Invenuki.png
Korea University Technology Holding Nuki.png
JB Lucky.png
Korea Venture Investment Lucky.png
Shinhan Lucky.png

© 2026 CELLTIUM

bottom of page